Effect of Adding TENS to Mediterranean Diet on Appetite and Liver Enzymes in Nonalcoholic Fatty Liver Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aims to identify the effect of adding TENS to the Mediterranean diet on appetite and liver enzymes in Nonalcoholic fatty liver patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2025
CompletedStudy Start
First participant enrolled
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 14, 2026
CompletedOctober 1, 2025
September 1, 2025
3 months
September 23, 2025
September 23, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Visual analogue scale for appetite (VAS)
This method is used to evaluate the appetite level of fatty liver patients before and after treatment procedures. This method usually consists of a set of questions assessing hunger, fullness/satisfaction, desire to eat and prospective food intake the question is presented with a 100 mm horizontal line scale.
12 weeks
Levels of liver transaminases aspartate transaminase (AST)
It will be measured pre and post-treatment for all participants in both groups.
12 weeks
Levels of liver alanine transaminase (ALT)
It will be measured pre and post-treatment for all participants in both groups.
12 weeks
Secondary Outcomes (3)
Body mass index (BMI)
12 weeks
Relative fat mass (RFM)
12 weeks
Fatigue Severity Scale (FSS)
12 weeks
Study Arms (2)
TENS + Mediterranean Diet
EXPERIMENTALThis group will consist of 25 patients, who will receive TENS treatment at T6 dermatome for 30 minutes, 3 times per week for 12 weeks, in addition to following Mediterranean diet for 12 weeks.
Mediterranean Diet
ACTIVE COMPARATORThis group will consist of 25 patients, who will follow Mediterranean diet only for 12 weeks.
Interventions
The negative/active pad surface electrode will be applied at the T6 dermatome on the abdomen (is located at the left upper quadrant of the abdomen, 2 cm below the ribcage at the left midclavicular line) for stimulation and the passive/positive electrode will be applied on the left T6 costovertebral junction to complete the circuit. * The specific parameters of TENS will be burst mode, 2.0 Hz frequency, and 300 micro-seconds width * The patients will receive 3 times 30 min session each week for a period of consecutive 12 weeks. * The intensity of TENS will be gradually increased from 0 mA till the subject felt a comfortable tingling sensation beneath the electrode without any muscle contraction and pain.
The recommended composition of Mediterranean diet regimen: is characterized by a high intake of plant foods, fruits, vegetables, breads and other cereals (traditionally minimally refined), potatoes, beans, nuts and seeds; minimally processed, fresh fruits as a typical dessert, with sweets containing sugars or honey a few times per week; .a high intake of olive oil (especially virgin and extra-virgin olive oil) as the main source of fat; a moderate intake of dairy products (mostly as cheese and yoghurt); zero to four eggs per week; low to moderate amounts of fish and poultry; low amounts of red meat. The diet plan included generally 50% carbohydrates (from vegetables, fruits, legumes, and whole grains), 35% fats (from healthy oils, nuts, seeds, and fish), and 15% protein (from legumes, fish, nuts, dairy, poultry, and eggs).
Eligibility Criteria
You may qualify if:
- The age will range from 35-45 years old.
- BMI (Body Mass Index 30-34.9 kg/m2.)
- With fatty liver infiltration confirmed by abdominal ultrasound
- Elevated of liver enzymes as a primary marker
- All patients are psychologically stable.
You may not qualify if:
- History of cardiovascular or respiratory disease.
- If any known endocrine diseases e.g. Hypothyroidism (which elevates liver enzymes and effects on appetite)
- Any acute or chronic illness causing elevated liver enzymes other than fatty liver e.g. Hepatitis b, Hepatitis c
- Any neurological illness or impairment can effect on sensation
- Patients associated with infections, mental or malignant conditions.
- Patients who have undergone any gastric surgery e.g. Bariatric surgery
- Taking dietary supplement for weight reduction.
- Patients who participating in any other exercise program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Internal Medicine Hospital Cairo University
Giza, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nesreen Ghareeb El-Nahas, PhD
Professor, Cairo university
- STUDY DIRECTOR
Salma Ibrahim AL Ghitany, PhD
Lecturer, Cairo university
- STUDY DIRECTOR
Shawky Abdelhamid Fouad Abdel Gawad
Professor, Cairo university
Central Study Contacts
Salma Ibrahim AL Ghitany, PhD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 23, 2025
First Posted
October 1, 2025
Study Start
September 30, 2025
Primary Completion
December 30, 2025
Study Completion
January 14, 2026
Last Updated
October 1, 2025
Record last verified: 2025-09